This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Uropharma Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Gabriel Korn – Innovator in Intermittent Intravesical Therapeutic Administration
Introduction
Gabriel Korn, an inventive mind based in Norwich, GB, has made significant strides in the field of medical technology. With a focus on enhancing patient care, he holds a patent that aims to improve urinary treatments through innovative designs.
Latest Patents
Korn's recent patent, titled "Intermittent Intravesical Therapeutic Administration System," presents a unique solution for administering medicaments directly into the bladder. The invention features an intravesical intermittent instillation catheter equipped with dual lumens: a urinary lumen for drainage and an instillation lumen for medicament delivery. This innovative system incorporates a sheath that can be slidably adjusted to facilitate either drainage or medication instillation, ensuring both efficiency and ease of use for medical professionals.
Career Highlights
Throughout his career, Gabriel Korn has focused on advancing medical devices that provide effective solutions for healthcare challenges. Working with Uropharma Limited, he has contributed to the company's mission of improving urinary health and patient outcomes. His dedication to innovation has positioned him as a key player in the development of cutting-edge medical technologies.
Collaborations
Korn’s work with Uropharma Limited underscores the importance of collaboration in the field of medical innovation. Teaming up with professionals in research and development, he has been able to take his ideas from concept to creation, ultimately resulting in patented technologies that benefit both healthcare providers and patients.
Conclusion
As an inventor, Gabriel Korn exemplifies the spirit of innovation within the medical device industry. His patented interventional system reflects a profound understanding of patient needs and medical processes. With continued dedication to research and development, Korn is poised to further impact the world of therapeutic administration in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile